Tirzepatide (Mounjaro, Zepbound) is a dual GIP and GLP-1 receptor agonist administered by subcutaneous injection for type 2 diabetes and chronic weight management
Telehealth companies where corporations, not doctors, improperly steer patient care to compounded "semaglutide" drugs using sham claims of personalization, violating California law
Semaglutide belongs to a class of drugs called GLP-1 receptor agonists that affect how your body regulates appetite and blood sugar
La prescripcin de tirzepatida requiere una evaluacin mdica completa que incluya historia clnica detallada, medicin de hemoglobina A1c (en pacientes diabticos), funcin renal y heptica, y evaluacin de factores de riesgo cardiovascular
You should try to increase the amount of cardio you do
The consensus among diabetes specialists and GPs is that Mounjaro should be used as part of a comprehensive diabetes management strategy that prioritises lifestyle modificationsincluding a balanced diet, regular physical activity, and weight managementalongside pharmacological treatment
